Dysregulated AKT1 signaling contributes to neuroinflammatory processes and insulin resistance, key mechanisms linking AD and T2DM (El Idrissi et al. 2021; Liao and Xu 2009; Arous et al. 2020). Here, AKT1 is linked to Insulin resistance.